de Almeida Faria Ana Cristina Ravazzani, Dall'Agnol Joceline Franco, Gouveia Aline Maciel, de Paiva Clara Inácio, Segalla Victoria Chechetto, Baena Cristina Pellegrino
Postgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná (PUCPR), Rua Imaculada Conceição, 1155, Curitiba, 80215-901, Brazil.
School of Medicine, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná, Brazil.
Diabetol Metab Syndr. 2022 Jul 27;14(1):105. doi: 10.1186/s13098-022-00872-3.
Type 2 Diabetes Mellitus (T2DM) patients are twice as likely to develop dementia. The study's goal was to evaluate cognitive performance and risk factors for cognitive decline in this population.
Prospective observational study was conducted with 400 T2DM adults, of whom, during routine baseline and follow-up appointments, had socio-demographic, clinical, and laboratory data collected, and underwent physical examination, screening for depression symptoms (Patient Health Questionaire-9-PHQ-9), and cognitive tests: Mini-Mental State Examination (MMSE), Semantic Verbal Fluency Test, Trail Making Test A/B, and Word Memory Tests. Each cognitive test score was converted to a z-score and its average resulted in a new variable called Global Cognitive z-Score [GCS(z)]. Averages of the cognitive test scores and GCS(z) at both moments were compared by the Student's T-Test for paired samples. Multivariate binary logistic regression models were built to assess the association of GCS(z) < zero with risk factors for cognitive decline at the baseline and follow-up.
After exclusions, 251 patients were eligible, being 56.6% female, mean age of 61.1 (± 9.8) years, 12.6 (± 8.9) years of DM duration, and 7.6 (± 4.2) years of school education. Follow-up had 134 patients reevaluated and took place after a mean of 18.4(± 5.0) months. Eleven (14%) patients with a GCS(z) ≥ 0 at baseline turned into a GCS(z) < 0 at follow-up. There were no significant differences between the means of cognitive test scores and GCS(z) at the two evaluation moments. At the baseline, the multivariate logistic regression model identified five risk factors associated with GCS(z) < zero: age ≥ 65 years, schooling ≤ 6 years, arterial hypertension, depression symptoms, and diabetic retinopathy (DR), with odds ratio (OR) and 95% confidence interval (CI95%) respectively: 5.46 (2.42-12.34); 12.19 (5.62-26.46); 2.55 (0.88-7.39); 3.53 (1.55-8.07) e 2.50 (1.18-5.34). At follow-up, the risk factors for GCS(z) < zero were: schooling ≤ 6 years, DM duration ≥ 10 years, depression symptoms, arterial hypertension, and cardiovascular disease (CVD), OR and CI95% respectively: 10.15 (3.68-28.01); 2.68 (0.96-7.48); 4.92 (1.77-13.70); 7.21 (1.38-35.71) e 5.76 (1.93-17.18).
Based on our results, cognitive evaluation and follow-up should be incorporated on the routine of T2DM patients, especially for those with advanced age, low education level, prolonged DM duration, arterial hypertension, depression symptoms, CVD, and DR.
2型糖尿病(T2DM)患者患痴呆症的可能性是正常人的两倍。本研究的目的是评估该人群的认知表现以及认知衰退的风险因素。
对400名成年T2DM患者进行前瞻性观察研究,在常规基线和随访预约期间,收集其社会人口统计学、临床和实验室数据,并进行体格检查、抑郁症状筛查(患者健康问卷-9-PHQ-9)以及认知测试:简易精神状态检查表(MMSE)、语义言语流畅性测试、连线测验A/B和单词记忆测试。每个认知测试分数转换为z分数,其平均值产生一个名为全球认知z分数[GCS(z)]的新变量。通过配对样本的学生t检验比较两个时间点的认知测试分数平均值和GCS(z)。建立多变量二元逻辑回归模型,以评估基线和随访时GCS(z)<0与认知衰退风险因素之间的关联。
排除后,251名患者符合条件,其中女性占56.6%,平均年龄61.1(±9.8)岁,糖尿病病程12.6(±8.9)年,受教育年限7.6(±4.2)年。134名患者接受了随访,平均随访时间为18.4(±5.0)个月。11名(14%)基线时GCS(z)≥0的患者在随访时变为GCS(z)<0。两个评估时间点的认知测试分数平均值和GCS(z)之间无显著差异。在基线时,多变量逻辑回归模型确定了与GCS(z)<0相关的五个风险因素:年龄≥65岁、受教育年限≤6年、动脉高血压、抑郁症状和糖尿病视网膜病变(DR),优势比(OR)和95%置信区间(CI95%)分别为:5.46(2.42 - 12.34);12.19(5.62 - 26.46);2.55(0.88 - 7.39);3.53(1.55 - 8.07)和2.50(1.18 - 5.34)。在随访时,GCS(z)<0的风险因素为:受教育年限≤6年、糖尿病病程≥10年、抑郁症状、动脉高血压和心血管疾病(CVD),OR和CI95%分别为:10.15(3.68 - 28.01);2.68(0.96 - 7.48);4.92(1.77 - 13.70);7.21(1.38 - 35.71)和5.76(1.93 - 17.18)。
基于我们的研究结果,认知评估和随访应纳入T2DM患者的常规诊疗中,尤其是对于那些年龄较大、教育水平低、糖尿病病程长、患有动脉高血压、抑郁症状、心血管疾病和糖尿病视网膜病变的患者。